University of Dundee

Latest News

February 2022

  • 28 Feb 2022

    Our annual Honours Project Symposium 2021 took place virtually at the end of term in December. On Friday, the prize winners were awarded their prizes.

  • Dr Rastko Sknepnek and Professor Kees Weijer
    23 Feb 2022

    Researchers at the University of Dundee have been awarded £2.1 million from UK Research and Innovation (UKRI) to determine how thousands of cells self-organise to form the embryonic body plan. The project, undertaken in collaboration with the University of Oxford and University College London, is one of nine funded by an £18 million investment from UKRI and Wellcome through the Physics of Life Strategic Priorities Fund.

  • Professor Jeff Williams
    14 Feb 2022

    Jeffrey Williams, world-leading expert on cell differentiation and a member of the division of Cell and Developmental Biology for 18 years until his retirement in 2016, died in January 2022.   Jeff was well known and highly respected world-wide for his influential work on the molecular control of cell differentiation in the social amoebae Dictyostelium discoideum. During his career, he published 178 articles.

  • Martin Balcerowicz
    07 Feb 2022

    Martin Balcerowicz joined the School in January to establish his own laboratory in the Division of Plant Sciences. He undertakes an Independent Investigator position which will be supported by a University Research Fellowship from the Royal Society. Martin’s research focuses on how temperature affects gene expression in plants, and how such changes are translated into growth responses. Temperature change has direct agricultural impacts wherein wheat and barley, each 1 °C increase above optimal growth temperature reduces crop yield by 5-6 %.

  • Kirby Swatek
    01 Feb 2022

    Kirby Swatek opened an independent research laboratory in the MRC PPU at the beginning of 2022. He has taken up a core funded MRC Investigator position to investigate the role played by the ubiquitin-like protein ISG15 in key immune responses that protect cells from invading viruses. 

January 2022

  • Left: Current lab members Hina Ojha and Olawale Raimi who co-led the work. Right: AlphaFold model of human PINK1.
    20 Jan 2022

    Mutations in PINK1 are the second most frequent cause of autosomal recessive early-onset Parkinson’s disease. PINK1 is activated upon mitochondrial damage to phosphorylate Ubiquitin and Parkin to stimulate Parkin E3 ligase activity, and this is critical for removal of damaged mitochondria by autophagy (mitophagy).

  • 19 Jan 2022

    Review of the Year 2021 took place virtually today with the former Interim Dean, Inke Näthke sharing the highlights of activity within the School from 2021. Returning Dean, Julian Blow concluded the review with a look to the future where he highlighted plans for the coming year. The Review included the presentation of the annual School prizes. Here are the winners: People’s Award The People’s Award is for positive contributions to School culture.

  • 19 Jan 2022

    A parasitic infection that affects millions of people around the world is to be targeted by a £2.5 million drug discovery programme at the Universities of Dundee, Aberystwyth and Cardiff. Schistosomiasis, also known as Bilharzia, is a parasitic infection caused by tiny flatworms that live within the blood vessels around either the intestines or bladder. The infection is found in many tropical and sub-tropical regions of the world and is estimated to cause more than 230 million clinical cases every year.

  • From left: Emily Dickie and Bill Carton
    19 Jan 2022

    Two researchers from the MRC PPU have been awarded places in the Scottish Universities Life Sciences Alliance (SULSA) Forging Futures Scheme. Bill Carton (Sapkota lab) and Emily Dickie (Alessi lab) will represent the University of Dundee in the scheme, which is running for the first time in 2022.

  • Pictured from left to right: Lucie Ellis-Taitt, Alessio Ciulli, Nicki Thompson, and Amol Rajan
    18 Jan 2022

    Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding. The annual Scrips Awards applaud the essential role that the pharmaceutical, biotech and other allied industries play in improving healthcare. The awards span the entire range of industry activities, from new drug launches and clinical trials, to innovative deals, outsourcing and fundraising.